Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 479.1M | 459.9M | 430.1M | 401.0M |
| Cost of revenue | 115.6M | 108.7M | 96.0M | 89.0M |
| Gross profit | 363.5M | 351.3M | 334.1M | 312.0M |
| Operating expense | ||||
| Research & development | 115.1M | 120.2M | 110.9M | 102.5M |
| Selling general and admin | 301.7M | 265.8M | 254.0M | 244.1M |
| Other operating expenses | — | — | — | — |
| Operating income | -53.2M | -34.7M | -30.8M | -34.7M |
| Non operating interest income | ||||
| Income | 21.4M | 22.0M | 22.5M | 21.7M |
| Expense | 1.4M | 1.4M | 1.4M | 1.2M |
| Other income expense | -3.5M | 3.3M | -3.1M | 269K |
| Pretax income | -36.8M | -10.8M | -12.8M | -13.9M |
| Tax provision | 1.7M | 2.0M | 2.5M | 1.1M |
| Net income | -38.5M | -12.8M | -15.3M | -15.1M |
| Basic EPS | -0.1 | 0.0 | 0.0 | 0.0 |
| Diluted EPS | -0.1 | 0.0 | 0.0 | 0.0 |
| Basic average shares | 345.7M | 344.0M | 342.4M | 340.6M |
| Diluted average shares | 345.7M | 344.0M | 342.4M | 340.6M |
| EBITDA | 6.9M | 26.8M | 20.3M | 16.9M |
| Net income from continuing op. | -38.5M | -12.8M | -15.3M | -15.1M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |